Back to search

Article

Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments

2023-04-20

Abstract excerpt

<h4>Aim: </h4> The aim of this study was to investigate genetic alterations within breast cancer in the setting of recurrent or de novo stage IV disease. Patients and Methods This study included 22 patients with recurrent breast cancer (n=19) and inoperable de novo stage IV breast cancer (n=3). For next generation sequencing, FoundationOne R CDx (F1CDx) (Foundation Medicine Inc., Cambridge, MA, USA) was performed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0ddb8a8e-934e-59d3-80ea-5ee626dd5b56
DOI
10.21203/rs.3.rs-2785270/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatmentsDOI 10.21203/rs.3.rs-2785270/v1
Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments.Semantic proximity
Concordance of genomic alterations between primary and recurrent breast cancer.Semantic proximity
Clinical Genomic Profiling to Identify Actionable Alterations for Very Early Relapsed Triple-Negative Breast Cancer Patients in the Chinese PopulationSemantic proximity
Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.Semantic proximity
Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesionsSemantic proximity
Genetic alterations and their association with clinicopathologic characteristics in advanced breast carcinomas: focusing on clinically actionable genetic alterations.Semantic proximity
Cell-free DNA comparative analysis of genomic landscape of first-line hormone-receptor positive metastatic breast cancer from US and ChinaSemantic proximity
Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.Semantic proximity
Comparative Genomic Profiling of Second Breast Cancers following First Ipsilateral Hormone Receptor-Positive Breast Cancers.Semantic proximity
Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue for Early Breast CancerSemantic proximity
From Static to Dynamic: Adaptive Molecular Subtyping in Treated Breast Cancers—Evidence from Single‐Center Retrospective Cohort StudySemantic proximity
Proteogenomics decodes the evolution of human ipsilateral breast cancerSemantic proximity
Select a neighboring publication to make it the new centre.